Interpretation of serum parathyroid hormone concentrations in dialysis patients: what do the KDIGO guidelines change for the clinical laboratory?
about
Growth retardation in children with kidney disease.Endorsement of the Kidney Disease Improving Global Outcomes (KDIGO) Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guidelines: a European Renal Best Practice (ERBP) commentary statement.Parathyroid hormone measurement in chronic kidney disease--an evolving issue for the nephrologist and the clinical laboratorist: minireview.Government Quality Measures: First Do No Harm.Variation in parathyroid hormone immunoassay results--a critical governance issue in the management of chronic kidney disease.
P2860
Interpretation of serum parathyroid hormone concentrations in dialysis patients: what do the KDIGO guidelines change for the clinical laboratory?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Interpretation of serum parath ...... e for the clinical laboratory?
@en
Interpretation of serum parath ...... e for the clinical laboratory?
@nl
type
label
Interpretation of serum parath ...... e for the clinical laboratory?
@en
Interpretation of serum parath ...... e for the clinical laboratory?
@nl
prefLabel
Interpretation of serum parath ...... e for the clinical laboratory?
@en
Interpretation of serum parath ...... e for the clinical laboratory?
@nl
P2860
P356
P1476
Interpretation of serum parath ...... e for the clinical laboratory?
@en
P2093
Etienne Cavalier
Guillaume Jean
P2860
P304
P356
10.1515/CCLM.2010.157
P577
2010-06-01T00:00:00Z